Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite the targeted approach of some cancer treatments, tumors can find ways to escape, leading patients to relapse. ImmPACT Bio will apply its Series B financing toward the development of cell therapies designed to prevent tumor escape.
The FDA has slapped a clinical hold on Takeda and Denali Therapeutics' phase 1-ready Alzheimer's candidate. Daiichi Sankyo is shutting down its Plexxikon R&D facility. Legend Biotech talks manufacturing learnings from Bristol Myers Squibb's CAR-T rival.
Moderna is doling out a little bit of its COVID-19 vaccine cash in a $45 million oncology research deal with Carisma Therapeutics to develop up to a dozen targets.
ATMPS Ltd, a UK developer of blockchain-based cell orchestration platforms for advanced therapies is collaborating with US quality and compliance consultancy, Assurea LLC, to develop a fully complaint blockchain approach for end-to-end supply chain management of cell and gene therapies.
The mRNA technology used in some coronavirus vaccines is expected to have many other uses, including temporarily reprogramming heart cells to remove scarring